ALKEM LABORATORIES
Back to Balance Sheet
|
ALKEM LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹4,783 Cr | ₹3,961 Cr | ₹3,995 Cr | ₹3,707 Cr | ₹4,805 Cr |
What is the latest Total Current Liabilities ratio of ALKEM LABORATORIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹4,783 Cr |
| Mar2025 | ₹3,961 Cr |
| Mar2024 | ₹3,995 Cr |
| Mar2023 | ₹3,707 Cr |
| Mar2022 | ₹4,805 Cr |
How is Total Current Liabilities of ALKEM LABORATORIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹4,783 Cr | 20.75 | |
| Mar2025 | ₹3,961 Cr | -0.85 | |
| Mar2024 | ₹3,995 Cr | 7.75 | |
| Mar2023 | ₹3,707 Cr | -22.85 | |
| Mar2022 | ₹4,805 Cr | - | |
Compare Total Current Liabilities of peers of ALKEM LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALKEM LABORATORIES | ₹62,944.3 Cr | 0.5% | 1.5% | -4.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,120.0 Cr | -3.2% | -5.4% | 12% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,390.0 Cr | 0.7% | 3.2% | 61.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,740.0 Cr | -2.8% | -3% | 32.6% | Stock Analytics | |
| CIPLA | ₹108,497.0 Cr | -2.9% | -3.3% | -10.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,925.0 Cr | -3.3% | 4.7% | -2.2% | Stock Analytics | |
ALKEM LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALKEM LABORATORIES | 0.5% |
1.5% |
-4.4% |
| SENSEX | -2.1% |
-5.9% |
-10.8% |
You may also like the below Video Courses